Janák D, Hála P, Mlček M, Popková M, Lacko S, Kudlička J, Kittnar O
Department of Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
Physiol Res. 2017 Dec 30;66(Suppl 4):S529-S536. doi: 10.33549/physiolres.933806.
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is a method used for the treatment most severe cases of decompensated heart failure. The purpose of this study was to evaluate the risk of the formation of microembolisms during VA-ECMO-based therapy. Heart failure was induced with simultaneous detection of microembolisms and the measurement of blood flow rate in the common carotid artery (CCA) without VA-ECMO (0 l/min) and at the VA-ECMO blood flow rate of 1, 2, 3 and 4 l/min. If embolisms for VA-ECMO 0 l/min and the individual regimes for VA-ECMO 1, 2, 3, 4 l/min are compared, a higher VA-ECMO flow rate is accompanied by a higher number of microembolisms. The final microembolism value at 16 min was for the VA-ECMO flow rate of 0 l/min 0.0 (0, 1), VA-ECMO l/min 7.5 (4, 19), VA-ECMO 2 l/min 12.5 (4, 26), VA-ECMO 3 l/min, 21.0 (18, 57) and VA-ECMO 4 l/min, 27.5 (21, 64). Such a comparison is statistically significant if VA-ECMO 0 vs. 4 l/min p<0.0001, 0 vs. 3 l/min p<0.01 and 1 vs. 4 l/min p<0.01 are compared. The results confirm that high VA-ECMO flow rates pose a risk with regards to the formation of a significantly higher number of microemboli in the blood circulation and that an increase in blood flow rates in the CCA corresponds to changes in the VA-ECMO flow rates.
静脉-动脉体外膜肺氧合(VA-ECMO)是一种用于治疗失代偿性心力衰竭最严重病例的方法。本研究的目的是评估基于VA-ECMO治疗期间微栓塞形成的风险。在未使用VA-ECMO(0升/分钟)以及VA-ECMO血流速度分别为1、2、3和4升/分钟的情况下,通过同步检测微栓塞和测量颈总动脉(CCA)中的血流速度来诱导心力衰竭。如果比较VA-ECMO 0升/分钟时的栓塞情况与VA-ECMO 1、2、3、4升/分钟各个模式下的栓塞情况,会发现较高的VA-ECMO血流速度伴随着更多的微栓塞。在16分钟时,VA-ECMO血流速度为0升/分钟时的最终微栓塞值为0.0(0,1),VA-ECMO 1升/分钟时为7.5(4,19),VA-ECMO 2升/分钟时为12.5(4,26),VA-ECMO 3升/分钟时为21.0(18,57),VA-ECMO 4升/分钟时为27.5(21,64)。如果比较VA-ECMO 0升/分钟与4升/分钟(p<0.0001)、0升/分钟与3升/分钟(p<0.01)以及1升/分钟与4升/分钟(p<0.01),这种比较具有统计学意义。结果证实,高VA-ECMO血流速度会导致血液循环中形成显著更多微栓子带来风险,并且CCA中血流速度的增加与VA-ECMO血流速度的变化相对应。